BHR-100 progesterone: Phase III start

Early next year, Besins' BHR Pharma LLC unit will begin the international Phase III SyNAPSe trial to compare a 5-day continuing IV infusion of BHR-100 vs. placebo given in 1,200 patients. Study treatm...